Hiroaki Aoki

Hiroaki Aoki

Auto-generated profile, based on publicly available information

Hiroaki Aoki

Aoki Obstetrics and Gynecology Clinic Tokyo Japan

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2016 in Fetal Diagnosis and Therapy
Verified
Journal Article
Closed access
Junichi HasegawaJunichi Hasegawa
Junichi Hasegawa
IKIkuno Kawabata
Ikuno Kawabata
YTYoshiharu Takeda
Yoshiharu Takeda
HAHiroaki Aoki
Hiroaki Aoki
TFTakehiko Fukami
Takehiko Fukami
J(Japanese Organization Of Prevention Of Preterm Delivery (Jopp)
Japanese Organization Of Prevention Of Preterm Delivery (Jopp)
Objective: To clarify whether distinguishing between the uterine isthmus and cervix can improve the accuracy of diagnosing placenta previa at term. Methods: A multicenter prospective observational study was conducted among pregnant women with suspected placenta previa at 20-24 weeks' gestation. Subjects were divided into the open isthmus group and closed isthmus group. The accuracy of diagnosing placenta previa at term was compared between the 2 groups. Results: We screened 9,341 patients, and 53 (0.6%) met the inclusion criteria. Nineteen cases with an open isthmus and 34 with a closed isthmus were followed. The accuracy for diagnosing placenta previa or a low-lying placenta at term was 94.7% in the open isthmus group and 26.5% in the closed isthmus group (p < 0.001). Elective or emergency Cesarean section was required in 100% of cases in the open isthmus group and 20.6% in the closed isthmus group (p < 0.001). Conclusion: A high prediction rate of placenta previa was obtained by using transvaginal ultrasound at 20-24 weeks' gestation after the isthmus opened by carefully distinguishing between the cervix and isthmus.

1 June 2019 in European Journal of Medical Genetics
Verified
Journal Article
Closed access
TSTaisuke Sato
Taisuke Sato
Osamu SamuraOsamu Samura
Osamu Samura
TMTomona Matsuoka
Tomona Matsuoka
MYMasaki Yoshida
Masaki Yoshida
HAHiroaki Aoki
Hiroaki Aoki
KHKenichiro Hata
Kenichiro Hata

31 August 2026 in The Journal of Dermatology
Verified
Journal Article
Open access
PDF file
SKSachi Koinuma
Sachi Koinuma
MGMikako Goto
Mikako Goto
JSJumpei Saito
Jumpei Saito
HAHiroaki Aoki
Hiroaki Aoki
SHSatoshi Hayashi
Satoshi Hayashi
TTTomoyoshi Takeshita
Tomoyoshi Takeshita
Patient–initiated therapy (PIT) is a treatment approach in which patients with recurrent herpes simplex self–administer medication at the onset of prodromal symptoms. PIT, which allows patients to receive medication in advance and initiate treatment at any time, is a therapeutic approach that alleviates the burden of urgent clinic visits for acute diseases like herpes simplex and benefits many people. Furthermore, its utility is particularly high for breastfeeding women for whom clinic visits can sometimes be difficult. When PIT is used in breastfeeding patients, potential drug transfer into breast milk and infant exposure must be considered. However, no studies have evaluated the extent of amenamevir transfer into human breast milk or its safety in infants. In this study, the relative infant dose (RID) was estimated from breast milk concentrations after a single oral dose of amenamevir. In the two cases evaluated, the estimated RID values were below 1%. This preliminary data suggest low estimated transfer of amenamevir into human milk after PIT. However, because breastfeeding was interrupted and infant exposure was not evaluated, clinical safety in breastfed infants remains undetermined. Trial Registration: Japan Registry of Clinical Trials identifier: jRCTs031230591